Janney Montgomery Scott LLC Grows Position in HCA Healthcare, Inc. (NYSE:HCA)

Janney Montgomery Scott LLC raised its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 18.1% in the 3rd quarter, Holdings Channel reports. The firm owned 18,087 shares of the company’s stock after acquiring an additional 2,766 shares during the period. Janney Montgomery Scott LLC’s holdings in HCA Healthcare were worth $7,351,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in HCA. CreativeOne Wealth LLC purchased a new position in shares of HCA Healthcare in the 1st quarter worth $231,000. Bessemer Group Inc. lifted its position in shares of HCA Healthcare by 51.2% during the first quarter. Bessemer Group Inc. now owns 7,629 shares of the company’s stock worth $2,543,000 after purchasing an additional 2,584 shares during the last quarter. Empowered Funds LLC grew its holdings in shares of HCA Healthcare by 54.3% in the first quarter. Empowered Funds LLC now owns 13,910 shares of the company’s stock worth $4,639,000 after purchasing an additional 4,893 shares during the last quarter. Swedbank AB purchased a new stake in HCA Healthcare in the 1st quarter valued at about $95,882,000. Finally, EP Wealth Advisors LLC increased its position in shares of HCA Healthcare by 1.6% during the second quarter. EP Wealth Advisors LLC now owns 225,146 shares of the company’s stock worth $72,335,000 after acquiring an additional 3,516 shares during the period. 62.73% of the stock is owned by institutional investors.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares in the company, valued at approximately $11,438,494.76. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 1.60% of the stock is currently owned by corporate insiders.

HCA Healthcare Stock Down 0.5 %

HCA Healthcare stock opened at $354.16 on Friday. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. HCA Healthcare, Inc. has a fifty-two week low of $226.48 and a fifty-two week high of $417.14. The company has a market cap of $89.71 billion, a PE ratio of 15.90, a PEG ratio of 1.39 and a beta of 1.68. The business’s 50-day simple moving average is $389.61 and its two-hundred day simple moving average is $356.03.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be issued a $0.66 dividend. This represents a $2.64 annualized dividend and a dividend yield of 0.75%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare’s dividend payout ratio (DPR) is currently 11.85%.

Wall Street Analyst Weigh In

Several research analysts have commented on the company. TD Cowen reduced their price objective on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a report on Monday, October 28th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $392.00 price objective on shares of HCA Healthcare in a research note on Tuesday, October 1st. Oppenheimer boosted their price target on shares of HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a report on Monday, October 28th. Royal Bank of Canada lifted their price objective on shares of HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a report on Friday, August 23rd. Finally, Morgan Stanley started coverage on HCA Healthcare in a research report on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 target price on the stock. Five research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $379.17.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.